Sign In
Buy LLY
$1,125.38
+42.15 (+3.89%)
At Close: Jun 04, 2026
Future Trillion-Dollar Companies: 7 Stocks to Invest in Now
02:41pm, Sunday, 10'th Dec 2023
As 2024 unfolds, the spotlight falls on identifying the next trillion-dollar stocks. This elite club, currently consisting of six corporate giants at this time, symbolizes financial might, market infl
Eli Lilly (LLY) Rises Higher Than Market: Key Facts
06:47pm, Friday, 08'th Dec 2023
The latest trading day saw Eli Lilly (LLY) settling at $598.05, representing a +1.66% change from its previous close.
Novo, Lilly rivals explore booming weight-loss drug market entry
09:58am, Friday, 08'th Dec 2023
Novo Nordisk and Eli Lilly have pulled ahead in the race for a slice of the weight-loss drugs market, expected to be worth $100 billion by the end of the decade, and rivals are looking to catch up thr
Could Eli Lilly Beat Novo Nordisk in the Billion-Dollar Weight Loss Market?
05:30am, Friday, 08'th Dec 2023
Novo Nordisk was first to market with its blockbuster weight loss treatment Wegovy. Doctors have prescribed Eli Lilly's diabetes treatment for weight loss.
Challenging the Magnificent 7: 3 Stocks on the Rise
05:15am, Friday, 08'th Dec 2023
While the benchmark S&P 500 index is up nearly 20% since the start of this year, the equal-weight version of the index is only up 6.2%. This is because the Magnificent 7 stocks, Alphabet (NASDAQ: GOO
Better Large-Cap Growth Fund: Schwab U.S. Large-Cap Growth or Vanguard Growth Index Fund?
08:45am, Thursday, 07'th Dec 2023
Large-cap growth stocks have been major drivers of total stock market returns over the past century. This fact has driven a sharp rise in the popularity of large-cap growth ETFs over the past two deca
Should You Buy Eli Lilly Stock Now or Wait for a Dip?
08:30am, Thursday, 07'th Dec 2023
Eli Lilly used to trade at no higher than 30 times earnings, but those days appear to be long gone. Investors are paying a big premium for the stock due to its highly effective weight-loss treatment.
'Ten-bagger' stocks are the 'holy grail': Strategist
12:00pm, Wednesday, 06'th Dec 2023
As Wall Street weighs whether markets can sustain November's rally, investors are spotting opportunities. eToro Global Markets Strategist Ben Laidler joined Yahoo Finance Live to analyze high-growth "
Eli Lilly weight loss drug Zepbound now available at pharmacies as rival Wegovy faces shortages
01:04pm, Tuesday, 05'th Dec 2023
Eli Lilly's drug serves as an alternative to rival obesity drugs such as Wegovy that are still facing supply issues.
Eli Lilly's weight loss drug Zepbound is now available at US pharmacies
12:42pm, Tuesday, 05'th Dec 2023
Eli Lilly and Co (NYSE:LLY) announced that its weight loss drug Zepbound is now available at pharmacies in the US, sending its shares slightly higher Tuesday. The treatment is expected to cost $25 p
Results from MONARCH 3 show a numerical improvement in overall survival (OS) of 13.1 months for women with HR+, HER2- metastatic breast cancer treated with Verzenio plus an aromatase inhibitor in the
Eli Lilly's obesity drug now available in U.S. pharmacies
08:09am, Tuesday, 05'th Dec 2023
Eli Lilly's recently approved obesity drug Zepbound is now available in U.S. pharmacies and could be available to some insured customers at $550 per month or half of the list price, the U.S. drugmaker
Eli Lilly's new obesity drug Zepbound added to major PBM formularies as it hits pharmacy shelves
08:05am, Tuesday, 05'th Dec 2023
Eli Lilly & Co. LLY, +0.28% said Tuesday its new obesity drug Zepbound has been added to a major pharmacy benefit manager's preferred formulary, or list of covered drugs, as it hits U.S. pharmacy shel
No more exercising? President RFK Jr.?
05:45am, Tuesday, 05'th Dec 2023
Denmark's Saxo Bank makes a tradition of making “outrageous predictions,” which every once in a while comes true. The bank counts as a win its 2022 prediction that the plan to end fossil fuels wil
Alzheimer's Disease Drug Development: Another Lost Year
03:58am, Tuesday, 05'th Dec 2023
Investing in most current Alzheimer's drug companies is not recommended because they are not likely to modify the disease. Compounds that inhibit oxidative stress may only slow down the progression of
